BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1688273)

  • 1. [Neurophysiology of cannabis].
    Spadone C
    Encephale; 1991; 17(1):17-22. PubMed ID: 1688273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis: pharmacology and toxicology in animals and humans.
    Adams IB; Martin BR
    Addiction; 1996 Nov; 91(11):1585-614. PubMed ID: 8972919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
    Bossong MG; Niesink RJ
    Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
    Hillard CJ; Harris RA; Bloom AS
    J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system: emotion, learning and addiction.
    Moreira FA; Lutz B
    Addict Biol; 2008 Jun; 13(2):196-212. PubMed ID: 18422832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular effects of cannabinoids.
    Martin BR
    Pharmacol Rev; 1986 Mar; 38(1):45-74. PubMed ID: 2872689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine effects of marijuana in the male: preclinical studies.
    Harclerode J
    NIDA Res Monogr; 1984; 44():46-64. PubMed ID: 6090909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism.
    Hayakawa K; Mishima K; Hazekawa M; Sano K; Irie K; Orito K; Egawa T; Kitamura Y; Uchida N; Nishimura R; Egashira N; Iwasaki K; Fujiwara M
    Brain Res; 2008 Jan; 1188():157-64. PubMed ID: 18021759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
    Ryan D; Drysdale AJ; Pertwee RG; Platt B
    Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel component of cannabis extract potentiates excitatory synaptic transmission in rat olfactory cortex in vitro.
    Whalley BJ; Wilkinson JD; Williamson EM; Constanti A
    Neurosci Lett; 2004 Jul; 365(1):58-63. PubMed ID: 15234473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling of the concentration--effect relationship of THC on central nervous system parameters and heart rate -- insight into its mechanisms of action and a tool for clinical research and development of cannabinoids.
    Strougo A; Zuurman L; Roy C; Pinquier JL; van Gerven JM; Cohen AF; Schoemaker RC
    J Psychopharmacol; 2008 Sep; 22(7):717-26. PubMed ID: 18583433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ; Gardner EL; Zukin RS
    J Pharmacol Exp Ther; 1987 May; 241(2):534-9. PubMed ID: 3033219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine aspects of cannabinoid action in female subprimates: search for sites of action.
    Tyrey L
    NIDA Res Monogr; 1984; 44():65-81. PubMed ID: 6090910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter concentrations and receptor binding in the rat brain.
    Ali SF; Newport GD; Scallet AC; Gee KW; Paule MG; Brown RM; Slikker W
    Neurotoxicology; 1989; 10(3):491-500. PubMed ID: 2576303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices.
    Reichman M; Nen W; Hokin LE
    Mol Pharmacol; 1988 Dec; 34(6):823-8. PubMed ID: 2849049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
    Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
    Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.
    Verhoeckx KC; Korthout HA; van Meeteren-Kreikamp AP; Ehlert KA; Wang M; van der Greef J; Rodenburg RJ; Witkamp RF
    Int Immunopharmacol; 2006 Apr; 6(4):656-65. PubMed ID: 16504929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of delta 9-tetrahydrocannabinol and cannabidiol on sodium-dependent high affinity choline uptake in the rat hippocampus.
    Lindamood C; Colasanti BK
    J Pharmacol Exp Ther; 1980 May; 213(2):216-21. PubMed ID: 6245205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delta-9-tetrahydrocannabinol pharmacokinetics].
    Goullé JP; Saussereau E; Lacroix C
    Ann Pharm Fr; 2008 Aug; 66(4):232-44. PubMed ID: 18847571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuropsychopharmacology of delta-9-tetrahydrocannabinol].
    Costentin J
    Ann Pharm Fr; 2008 Aug; 66(4):219-31. PubMed ID: 18847570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.